Navigation Links
BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
Date:12/7/2009

ut PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include (1) SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine, (2) Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection, (3) Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents, (4) RypVax(TM) - a recombinant dual antigen vaccine for plague, and (5) a third generation rPA anthrax vaccine.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) unde
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vivakor Announces Additions to Board of Directors and Scientific Advisory Board
2. ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis
3. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
4. BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
5. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
6. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
7. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
8. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
9. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
10. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
11. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Canada (PRWEB) July 14, 2014 ... executives from across the clinical trials space, representing ... eCongress webinar series entitled “Optimizing Patient Participation in ... eCongress kicked off with internationally renowned R&D expert, ... Keynote address on Reinventing Drug Development through Patient ...
(Date:7/13/2014)... 2014 Deep Research Report on Global and China ... on the current state of the Nano Silver industry ... basic overview of the industry, including definitions, applications and ... market analysis are provided with a focus on history, ... comparison between the international and Chinese situation is also ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... http://photos.prnewswire.com/prnh/20130307/600769 ... (either DNA or RNA) into cells. This technology helps ... cells and protein metabolism by affecting the nuclear genes. ...
(Date:7/11/2014)... SEATTLE , July 11, 2014  Researchers ... navigate three-dimensional images. The new technology, called Virtual ... of small structures like neurons and synapses using ... Finger,s unique technology makes 3D imaging studies orders ... resources at an unprecedented level across many areas ...
Breaking Biology Technology:Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 52014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3
... SHANGHAI, China, Aug. 22 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. ... leading Chinese firm specializing in the manufacture,research, ... today that it has signed an agreement ... Dairy") (SSE: 600597) to supply probiotics for ...
... UniCare,s HealthWave Members with Valuable Local ... ... Health Plan of Kansas,Inc. today announced the opening of its first ... enrollees living in,the Topeka area, the CRC will provide access to ...
... - Canadian Biotechnology Company confirms commercial expression levels ... variant and clarifies status of native Apo AI ... Genetics Inc.,(TSX:SBS), a biotechnology company developing a portfolio ... updated a release,issued on July 12, 2007 announcing ...
Cached Biology Technology:China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 2China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 3UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees 2SemBioSys updates Apo AI development program 2SemBioSys updates Apo AI development program 3SemBioSys updates Apo AI development program 4
(Date:7/14/2014)... at the University of East Anglia have shown how ... growth in cancer patients. , Research published today ... are responsible for the drug,s success in shrinking tumours. ... help develop a synthetic equivalent with anti-cancer properties. ... Complutense de Madridin, Spain. The team used samples of ...
(Date:7/13/2014)... in women suggests that experiencing one or more stressful ... can slow the body,s metabolism, potentially contributing to weight ... day,s stressors before giving them a meal consisting of ... then measured their metabolic rate how long it ... and took measures of blood sugar, triglycerides, insulin and ...
(Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4Belize's lobster, conch, and fish populations rebuild in no-take zones 2
... appears to have "snipped off the ends" of its ... that infects human cells, according to research published today ... E. cuniculi , a parasitic fungus commonly found ... humans, has been widely regarded as having the smallest ...
... Global Rainmakers, Inc. (GRI), a Puerto Rico based ... today announced the appointment of James Demitrieus as Chief ... firm operations as it diversifies its product offering ... comes to GRI with over 30 years of ...
... fan out on Capitol Hill on Tuesday to engage ... to practice communicating the importance of supporting scientific discovery ... The undergraduate and graduate students participating in "Hill ... Molecular Biology, have a number of messages they intend ...
Cached Biology News:Genomic 'haircut' makes world's tiniest genome even smaller: UBC research 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 2Global Rainmakers Appoints James M. Demitrieus as Chief Operating Officer 3‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 2‘Scientific leaders of the future’ gear up for important talks on Capitol Hill 3
...
... Arrays can be used to test the ... and sera that are commonly used as ... contains spots for 21 different protein preparations ... antibody crossreactivity and species specificity, QC of ...
... DNA sequencing is the experimental process ... DNA region. The automated DNA Sequencing is ... thermostable DNA polymerase, which allows cycle sequencing ... and detected in a capillary instrument controlled ...
... On-Demand Cytometry The Guava ... blue laser based multiparameter cytometer with built-in ... you can screen plates of cells and ... of manipulating multiple tubes or having the ...
Biology Products: